Bartek J - Search Results

1

Alternative splicing and mutation status of CHEK2 in stage III breast cancer.

Staalesen V, Falck J, Geisler S, Bartkova J, Børresen-Dale AL, Lukas J, Lillehaug JR, Bartek J, Lønning PE. Staalesen V, et al. Among authors: bartek j. Oncogene. 2004 Nov 4;23(52):8535-44. doi: 10.1038/sj.onc.1207928. Oncogene. 2004. PMID: 15361853

2

The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways.

Falck J, Petrini JH, Williams BR, Lukas J, Bartek J. Falck J, et al. Among authors: bartek j. Nat Genet. 2002 Mar;30(3):290-4. doi: 10.1038/ng845. Epub 2002 Feb 19. Nat Genet. 2002. PMID: 11850621

3

Deregulated human Cdc14A phosphatase disrupts centrosome separation and chromosome segregation.

Mailand N, Lukas C, Kaiser BK, Jackson PK, Bartek J, Lukas J. Mailand N, et al. Among authors: bartek j. Nat Cell Biol. 2002 Apr;4(4):317-22. doi: 10.1038/ncb777. Nat Cell Biol. 2002. PMID: 11901424

4

Distinct phosphorylation events regulate p130- and p107-mediated repression of E2F-4.

Farkas T, Hansen K, Holm K, Lukas J, Bartek J. Farkas T, et al. Among authors: bartek j. J Biol Chem. 2002 Jul 26;277(30):26741-52. doi: 10.1074/jbc.M200381200. Epub 2002 May 2. J Biol Chem. 2002. PMID: 12006580 Free article.

5

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.

Vahteristo P, Bartkova J, Eerola H, Syrjäkoski K, Ojala S, Kilpivaara O, Tamminen A, Kononen J, Aittomäki K, Heikkilä P, Holli K, Blomqvist C, Bartek J, Kallioniemi OP, Nevanlinna H. Vahteristo P, et al. Among authors: bartek j. Am J Hum Genet. 2002 Aug;71(2):432-8. doi: 10.1086/341943. Epub 2002 Jul 28. Am J Hum Genet. 2002. PMID: 12094328 Free PMC article.

6

Sensitivity to growth suppression by 1alpha,25-dihydroxyvitamin D(3) among MCF-7 clones correlates with Vitamin D receptor protein induction.

Jensen SS, Madsen MW, Lukas J, Bartek J, Binderup L. Jensen SS, et al. Among authors: bartek j. J Steroid Biochem Mol Biol. 2002 Jun;81(2):123-33. doi: 10.1016/s0960-0760(02)00057-2. J Steroid Biochem Mol Biol. 2002. PMID: 12137801

7

E2F activity is essential for survival of Myc-overexpressing human cancer cells.

Santoni-Rugiu E, Duro D, Farkas T, Mathiasen IS, Jäättelä M, Bartek J, Lukas J. Santoni-Rugiu E, et al. Among authors: bartek j. Oncogene. 2002 Sep 19;21(42):6498-509. doi: 10.1038/sj.onc.1205828. Oncogene. 2002. PMID: 12226753

8

Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability.

Mailand N, Podtelejnikov AV, Groth A, Mann M, Bartek J, Lukas J. Mailand N, et al. Among authors: bartek j. EMBO J. 2002 Nov 1;21(21):5911-20. doi: 10.1093/emboj/cdf567. EMBO J. 2002. PMID: 12411508 Free PMC article.

9

53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer.

DiTullio RA Jr, Mochan TA, Venere M, Bartkova J, Sehested M, Bartek J, Halazonetis TD. DiTullio RA Jr, et al. Among authors: bartek j. Nat Cell Biol. 2002 Dec;4(12):998-1002. doi: 10.1038/ncb892. Nat Cell Biol. 2002. PMID: 12447382

10

DNA repair: Damage alert.

Bartek J, Lukas J. Bartek J, et al. Nature. 2003 Jan 30;421(6922):486-8. doi: 10.1038/421486a. Nature. 2003. PMID: 12556872 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

732 results

Search Page